ReP USP - Resultado da busca

Artigo de periodico
School-based HPV vaccination program implementation in municipalities of the São Paulo State, Brazil, from 2015 to 2018 (2025)
Piorelli, Roberta de Oliveira; Sato, Helena Keiko; Araujo, Nubia Virginia Da'villa Limeira de; Braga, Patricia Emilia; Miyaji, Karina Takesaki; Sartori, Ana Marli Christovam
Fonte: Cadernos de Saúde Pública. Unidade: FM
Assuntos: ESCOLAS, VACINAÇÃO, HPV
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIORELLI, Roberta de Oliveira et al. School-based HPV vaccination program implementation in municipalities of the São Paulo State, Brazil, from 2015 to 2018. Cadernos de Saúde Pública, v. 41, n. 2, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/85004. Acesso em: 02 dez. 2025.
APA
Piorelli, R. de O., Sato, H. K., Araujo, N. V. D. 'villa L. de, Braga, P. E., Miyaji, K. T., & Sartori, A. M. C. (2025). School-based HPV vaccination program implementation in municipalities of the São Paulo State, Brazil, from 2015 to 2018. Cadernos de Saúde Pública, 41( 2). doi:10.1590/0102-311XEN127423
NLM
Piorelli R de O, Sato HK, Araujo NVD'villa L de, Braga PE, Miyaji KT, Sartori AMC. School-based HPV vaccination program implementation in municipalities of the São Paulo State, Brazil, from 2015 to 2018 [Internet]. Cadernos de Saúde Pública. 2025 ; 41( 2):[citado 2025 dez. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/85004
Vancouver
Piorelli R de O, Sato HK, Araujo NVD'villa L de, Braga PE, Miyaji KT, Sartori AMC. School-based HPV vaccination program implementation in municipalities of the São Paulo State, Brazil, from 2015 to 2018 [Internet]. Cadernos de Saúde Pública. 2025 ; 41( 2):[citado 2025 dez. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/85004
Artigo de periodico
Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/ BioNTech) in immunocompromised and immunocompetent individuals (2025)
Miyaji, Karina Takesaki; Ibrahim, Karim Yaqub; Infante, Vanessa; Moreira, Raquel Megale; Santos, Carolina Ferreira dos; Belizario, Juliana de Cassia; Pinto, Maria Isabel de Moraes; Marinho, Ana Karolina Barreto Berselli; Pereira, Juliana Marquezi; Sartori, Ana Marli Christovam
Fonte: Revista do Instituto de Medicina Tropical de São Paulo. Unidade: FM
Assuntos: COVID-19, VACINAÇÃO, RNA MENSAGEIRO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIYAJI, Karina Takesaki et al. Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/ BioNTech) in immunocompromised and immunocompetent individuals. Revista do Instituto de Medicina Tropical de São Paulo, v. 67, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/82819. Acesso em: 02 dez. 2025.
APA
Miyaji, K. T., Ibrahim, K. Y., Infante, V., Moreira, R. M., Santos, C. F. dos, Belizario, J. de C., et al. (2025). Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/ BioNTech) in immunocompromised and immunocompetent individuals. Revista do Instituto de Medicina Tropical de São Paulo, 67. doi:10.1590/S1678-9946202567002
NLM
Miyaji KT, Ibrahim KY, Infante V, Moreira RM, Santos CF dos, Belizario J de C, Pinto MI de M, Marinho AKBB, Pereira JM, Sartori AMC. Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/ BioNTech) in immunocompromised and immunocompetent individuals [Internet]. Revista do Instituto de Medicina Tropical de São Paulo. 2025 ; 67[citado 2025 dez. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/82819
Vancouver
Miyaji KT, Ibrahim KY, Infante V, Moreira RM, Santos CF dos, Belizario J de C, Pinto MI de M, Marinho AKBB, Pereira JM, Sartori AMC. Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/ BioNTech) in immunocompromised and immunocompetent individuals [Internet]. Revista do Instituto de Medicina Tropical de São Paulo. 2025 ; 67[citado 2025 dez. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/82819
Artigo de periodico
Immunogenicity of COVID-19 adsorbed inactivated vaccine (CoronaVac) and additional doses of mRNA BNT162b2 vaccine in immunocompromised adults compared with immunocompetent persons (2024)
Ibrahim, Karim Yaqub; Moreira, Raquel Megale; Santos, Carolina Ferreira dos; Strabelli, Tania Mara Varejao; Belizario, Juliana de Cassia; Pinto, Maria Isabel de Moraes; Marinho, Ana Karolina Barreto Berselli; Pereira, Juliana Marquezi; Mello, Liliane Saraiva de; Sartori, Ana Marli Christovam
Fonte: Revista do instituto de medicina tropical de São Paulo. Unidade: FM
Assuntos: COVID-19, VACINAS, IMUNOGENICIDADE DA VACINA, HOSPEDEIRO IMUNOCOMPROMETIDO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
IBRAHIM, Karim Yaqub et al. Immunogenicity of COVID-19 adsorbed inactivated vaccine (CoronaVac) and additional doses of mRNA BNT162b2 vaccine in immunocompromised adults compared with immunocompetent persons. Revista do instituto de medicina tropical de São Paulo, v. 66, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76944. Acesso em: 02 dez. 2025.
APA
Ibrahim, K. Y., Moreira, R. M., Santos, C. F. dos, Strabelli, T. M. V., Belizario, J. de C., Pinto, M. I. de M., et al. (2024). Immunogenicity of COVID-19 adsorbed inactivated vaccine (CoronaVac) and additional doses of mRNA BNT162b2 vaccine in immunocompromised adults compared with immunocompetent persons. Revista do instituto de medicina tropical de São Paulo, 66. doi:10.1590/S1678-9946202466024
NLM
Ibrahim KY, Moreira RM, Santos CF dos, Strabelli TMV, Belizario J de C, Pinto MI de M, Marinho AKBB, Pereira JM, Mello LS de, Sartori AMC. Immunogenicity of COVID-19 adsorbed inactivated vaccine (CoronaVac) and additional doses of mRNA BNT162b2 vaccine in immunocompromised adults compared with immunocompetent persons [Internet]. Revista do instituto de medicina tropical de São Paulo. 2024 ; 66[citado 2025 dez. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76944
Vancouver
Ibrahim KY, Moreira RM, Santos CF dos, Strabelli TMV, Belizario J de C, Pinto MI de M, Marinho AKBB, Pereira JM, Mello LS de, Sartori AMC. Immunogenicity of COVID-19 adsorbed inactivated vaccine (CoronaVac) and additional doses of mRNA BNT162b2 vaccine in immunocompromised adults compared with immunocompetent persons [Internet]. Revista do instituto de medicina tropical de São Paulo. 2024 ; 66[citado 2025 dez. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76944
Artigo de periodico
The decline of measles antibody titers in previously vaccinated adults: a cross-sectional analysis (2024)
Castineiras, Anna Carla Pinto; Sales, Amanda Caroline Ribeiro; Picone, Camila de Melo; Diogo, Constancia Lima; Rossi, atila Duque; Galliez, Rafael Mello; Ferreira Junior, Orlando da Costa; Castineiras, Terezinha Marta Pereira Pinto; Lopes, Marta Heloísa ; Sartori, Ana Marli Christovam
Fonte: Revista do Instituto de Medicina Tropical de São Paulo. Unidade: FM
Assuntos: VACINAÇÃO, SARAMPO, ESTUDOS SOROEPIDEMIOLÓGICOS, PROFISSIONAIS DA SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTINEIRAS, Anna Carla Pinto et al. The decline of measles antibody titers in previously vaccinated adults: a cross-sectional analysis. Revista do Instituto de Medicina Tropical de São Paulo, v. 66, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58896. Acesso em: 02 dez. 2025.
APA
Castineiras, A. C. P., Sales, A. C. R., Picone, C. de M., Diogo, C. L., Rossi, atila D., Galliez, R. M., et al. (2024). The decline of measles antibody titers in previously vaccinated adults: a cross-sectional analysis. Revista do Instituto de Medicina Tropical de São Paulo, 66. doi:10.1590/S1678-9946202466004
NLM
Castineiras ACP, Sales ACR, Picone C de M, Diogo CL, Rossi atila D, Galliez RM, Ferreira Junior O da C, Castineiras TMPP, Lopes MH, Sartori AMC. The decline of measles antibody titers in previously vaccinated adults: a cross-sectional analysis [Internet]. Revista do Instituto de Medicina Tropical de São Paulo. 2024 ; 66[citado 2025 dez. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58896
Vancouver
Castineiras ACP, Sales ACR, Picone C de M, Diogo CL, Rossi atila D, Galliez RM, Ferreira Junior O da C, Castineiras TMPP, Lopes MH, Sartori AMC. The decline of measles antibody titers in previously vaccinated adults: a cross-sectional analysis [Internet]. Revista do Instituto de Medicina Tropical de São Paulo. 2024 ; 66[citado 2025 dez. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58896
Artigo de periodico
Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection (2024)
Freitas, Vera Lucia Teixeira de ; Novaes, Christina Terra Gallafrio; Sartori, Ana Marli Christovam ; Carvalho, Noemia Barbosa; Silva, Sheila Cristina Vicente da; Nakanishi, erika Shimoda; Salvador, Fernando; Castro, Cleudson Nery de; Richero, Carolina Bonilla ; Yasuda, Maria Aparecida Shikanai
Fonte: Plos neglected tropical diseases. Unidade: FM
Assuntos: INFECÇÕES OPORTUNISTAS, HIV, TRYPANOSOMA CRUZI, BIOMARCADORES, TESTES SOROLÓGICOS, REAÇÃO EM CADEIA POR POLIMERASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Vera Lucia Teixeira de et al. Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection. Plos neglected tropical diseases, v. 18, n. 2, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58892. Acesso em: 02 dez. 2025.
APA
Freitas, V. L. T. de, Novaes, C. T. G., Sartori, A. M. C., Carvalho, N. B., Silva, S. C. V. da, Nakanishi, erika S., et al. (2024). Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection. Plos neglected tropical diseases, 18( 2). doi:10.1371/journal.pntd.0011961
NLM
Freitas VLT de, Novaes CTG, Sartori AMC, Carvalho NB, Silva SCV da, Nakanishi erika S, Salvador F, Castro CN de, Richero CB, Yasuda MAS. Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection [Internet]. Plos neglected tropical diseases. 2024 ; 18( 2):[citado 2025 dez. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58892
Vancouver
Freitas VLT de, Novaes CTG, Sartori AMC, Carvalho NB, Silva SCV da, Nakanishi erika S, Salvador F, Castro CN de, Richero CB, Yasuda MAS. Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection [Internet]. Plos neglected tropical diseases. 2024 ; 18( 2):[citado 2025 dez. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58892
Artigo de periodico
Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation (2023)
Randi, Bruno Azevedo; Fernandes, Eder Gatti; Higashino, Hermes Ryoiti; Lopes, Marta Heloísa ; Rocha, Vanderson Geraldo ; Costa, Sílvia Figueiredo ; Sartori, Ana Marli Christovam
Fonte: Revista do instituto de medicina tropical de sao paulo. Unidade: FM
Assuntos: CÉLULAS-TRONCO, VACINAS VIRAIS, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RANDI, Bruno Azevedo et al. Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation. Revista do instituto de medicina tropical de sao paulo, v. 65, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52956. Acesso em: 02 dez. 2025.
APA
Randi, B. A., Fernandes, E. G., Higashino, H. R., Lopes, M. H., Rocha, V. G., Costa, S. F., & Sartori, A. M. C. (2023). Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation. Revista do instituto de medicina tropical de sao paulo, 65. doi:10.1590/S1678-9946202365021
NLM
Randi BA, Fernandes EG, Higashino HR, Lopes MH, Rocha VG, Costa SF, Sartori AMC. Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation [Internet]. Revista do instituto de medicina tropical de sao paulo. 2023 ; 65[citado 2025 dez. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52956
Vancouver
Randi BA, Fernandes EG, Higashino HR, Lopes MH, Rocha VG, Costa SF, Sartori AMC. Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation [Internet]. Revista do instituto de medicina tropical de sao paulo. 2023 ; 65[citado 2025 dez. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52956
Artigo de periodico
The methodological quality of economic evaluations of measles outbreaks: A systematic review of cost-of-illness studies (2023)
Soarez, Patricia Coelho De ; Rozmana, Luciana Martins ; Fonseca, Taiane Siraisi; Borsari, Pietro Rodrigo; Percio, Jadher ; Barrera, Lely Stella Guzman; Sartori, Ana Marli Christovam
Fonte: Vaccine. Unidade: FM
Assuntos: REVISÃO SISTEMÁTICA, CUSTOS DOS CUIDADOS DE SAÚDE, SARAMPO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOAREZ, Patricia Coelho De et al. The methodological quality of economic evaluations of measles outbreaks: A systematic review of cost-of-illness studies. Vaccine, v. 41, n. 7, p. 1319-1332, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54767. Acesso em: 02 dez. 2025.
APA
Soarez, P. C. D., Rozmana, L. M., Fonseca, T. S., Borsari, P. R., Percio, J., Barrera, L. S. G., & Sartori, A. M. C. (2023). The methodological quality of economic evaluations of measles outbreaks: A systematic review of cost-of-illness studies. Vaccine, 41( 7), 1319-1332. doi:10.1016/j.vaccine.2023.01.015
NLM
Soarez PCD, Rozmana LM, Fonseca TS, Borsari PR, Percio J, Barrera LSG, Sartori AMC. The methodological quality of economic evaluations of measles outbreaks: A systematic review of cost-of-illness studies [Internet]. Vaccine. 2023 ; 41( 7): 1319-1332.[citado 2025 dez. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54767
Vancouver
Soarez PCD, Rozmana LM, Fonseca TS, Borsari PR, Percio J, Barrera LSG, Sartori AMC. The methodological quality of economic evaluations of measles outbreaks: A systematic review of cost-of-illness studies [Internet]. Vaccine. 2023 ; 41( 7): 1319-1332.[citado 2025 dez. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54767
Artigo de periodico
Human Papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in Sao Paulo, Brazil (2022)
Miyaji, Karina Takesaki; Infante, Vanessa; Picone, Camila de Melo; Levi, Jose Eduardo; Oliveira, Ana Carolina Soares de; Lara, Amanda Nazareth; Tacla, Maricy; Dillner, Joakim; Kann, Hanna; Eklund, Carina; Sartori, Ana Marli Christovam
Fonte: Plos one. Unidade: FM
Assuntos: HPV, INFECÇÕES POR PAPILLOMAVIRUS, TESTES SOROLÓGICOS, PREVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIYAJI, Karina Takesaki et al. Human Papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in Sao Paulo, Brazil. Plos one, v. 17, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0262724. Acesso em: 02 dez. 2025.
APA
Miyaji, K. T., Infante, V., Picone, C. de M., Levi, J. E., Oliveira, A. C. S. de, Lara, A. N., et al. (2022). Human Papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in Sao Paulo, Brazil. Plos one, 17( 1). doi:10.1371/journal.pone.0262724
NLM
Miyaji KT, Infante V, Picone C de M, Levi JE, Oliveira ACS de, Lara AN, Tacla M, Dillner J, Kann H, Eklund C, Sartori AMC. Human Papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in Sao Paulo, Brazil [Internet]. Plos one. 2022 ; 17( 1):[citado 2025 dez. 02 ] Available from: https://doi.org/10.1371/journal.pone.0262724
Vancouver
Miyaji KT, Infante V, Picone C de M, Levi JE, Oliveira ACS de, Lara AN, Tacla M, Dillner J, Kann H, Eklund C, Sartori AMC. Human Papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in Sao Paulo, Brazil [Internet]. Plos one. 2022 ; 17( 1):[citado 2025 dez. 02 ] Available from: https://doi.org/10.1371/journal.pone.0262724
Artigo de periodico
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases (2022)
Aikawa, Nadia Emi; Kupa, Leonard de Vinci Kanda; Medeiros-Ribeiro, Ana Cristina; Saad, Carla Goncalves Schahin; Pereira, Rosa Maria Rodrigues ; Shinjo, Samuel Katsuyuki ; Sartori, Ana Marli Christovam ; Antonangelo, Leila ; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira
Fonte: Annals of the rheumatic diseases. Unidade: FM
Assuntos: VACINAÇÃO, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AIKAWA, Nadia Emi et al. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases. Annals of the rheumatic diseases, v. 81, n. 7, p. 1036-1043, 2022Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2021-222096. Acesso em: 02 dez. 2025.
APA
Aikawa, N. E., Kupa, L. de V. K., Medeiros-Ribeiro, A. C., Saad, C. G. S., Pereira, R. M. R., Shinjo, S. K., et al. (2022). Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases. Annals of the rheumatic diseases, 81( 7), 1036-1043. doi:10.1136/annrheumdis-2021-222096
NLM
Aikawa NE, Kupa L de VK, Medeiros-Ribeiro AC, Saad CGS, Pereira RMR, Shinjo SK, Sartori AMC, Antonangelo L, Silva CAA da, Bonfa ESD de O. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 7): 1036-1043.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1136/annrheumdis-2021-222096
Vancouver
Aikawa NE, Kupa L de VK, Medeiros-Ribeiro AC, Saad CGS, Pereira RMR, Shinjo SK, Sartori AMC, Antonangelo L, Silva CAA da, Bonfa ESD de O. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 7): 1036-1043.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1136/annrheumdis-2021-222096
Artigo de periodico
Impact of polio vaccines (oral polio vaccine-OPV or inactivated polio vaccine-IPV) on rotavirus vaccine-associated intussusception (2022)
Rodrigues, Camila Cristina Martini; Fernandes, Eder Gatti; Santos, Paulo Piva dos; Eguti, Renato Yoshio; Lima, Antonio Carlos Pedroso de ; Tunes, Gisela ; Sartori, Ana Marli Christovam
Fonte: Human vaccines & immunotherapeutics. Unidades: FM, IME
Assuntos: VACINAS VIRAIS, ROTAVIRUS, HOSPITALIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Camila Cristina Martini et al. Impact of polio vaccines (oral polio vaccine-OPV or inactivated polio vaccine-IPV) on rotavirus vaccine-associated intussusception. Human vaccines & immunotherapeutics, v. 18, n. 5, 2022Tradução . . Disponível em: https://doi.org/10.1080/21645515.2022.2063594. Acesso em: 02 dez. 2025.
APA
Rodrigues, C. C. M., Fernandes, E. G., Santos, P. P. dos, Eguti, R. Y., Lima, A. C. P. de, Tunes, G., & Sartori, A. M. C. (2022). Impact of polio vaccines (oral polio vaccine-OPV or inactivated polio vaccine-IPV) on rotavirus vaccine-associated intussusception. Human vaccines & immunotherapeutics, 18( 5). doi:10.1080/21645515.2022.2063594
NLM
Rodrigues CCM, Fernandes EG, Santos PP dos, Eguti RY, Lima ACP de, Tunes G, Sartori AMC. Impact of polio vaccines (oral polio vaccine-OPV or inactivated polio vaccine-IPV) on rotavirus vaccine-associated intussusception [Internet]. Human vaccines & immunotherapeutics. 2022 ; 18( 5):[citado 2025 dez. 02 ] Available from: https://doi.org/10.1080/21645515.2022.2063594
Vancouver
Rodrigues CCM, Fernandes EG, Santos PP dos, Eguti RY, Lima ACP de, Tunes G, Sartori AMC. Impact of polio vaccines (oral polio vaccine-OPV or inactivated polio vaccine-IPV) on rotavirus vaccine-associated intussusception [Internet]. Human vaccines & immunotherapeutics. 2022 ; 18( 5):[citado 2025 dez. 02 ] Available from: https://doi.org/10.1080/21645515.2022.2063594
Artigo de periodico
Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases (2022)
Aikawa, Nadia Emi; Balbi, Verena Andrade; Borba Neto, Eduardo Ferreira ; Tonacio, Adriana Coracini; Sallum, Adriana Maluf Elias; Campos, Lucia Maria Arruda; Sartori, Ana Marli Christovam ; Antonangelo, Leila ; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira
Fonte: Vaccine: x. Unidade: FM
Assuntos: IMUNOGENICIDADE DA VACINA, DOENÇAS AUTOIMUNES, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AIKAWA, Nadia Emi et al. Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases. Vaccine: x, v. 10, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jvacx.2021.100131. Acesso em: 02 dez. 2025.
APA
Aikawa, N. E., Balbi, V. A., Borba Neto, E. F., Tonacio, A. C., Sallum, A. M. E., Campos, L. M. A., et al. (2022). Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases. Vaccine: x, 10. doi:10.1016/j.jvacx.2021.100131
NLM
Aikawa NE, Balbi VA, Borba Neto EF, Tonacio AC, Sallum AME, Campos LMA, Sartori AMC, Antonangelo L, Silva CAA da, Bonfa ESD de O. Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases [Internet]. Vaccine: x. 2022 ; 10[citado 2025 dez. 02 ] Available from: https://doi.org/10.1016/j.jvacx.2021.100131
Vancouver
Aikawa NE, Balbi VA, Borba Neto EF, Tonacio AC, Sallum AME, Campos LMA, Sartori AMC, Antonangelo L, Silva CAA da, Bonfa ESD de O. Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases [Internet]. Vaccine: x. 2022 ; 10[citado 2025 dez. 02 ] Available from: https://doi.org/10.1016/j.jvacx.2021.100131
Artigo de periodico
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study (2022)
Aikawa, Nadia E; Kupa, Leonard de Vinci Kanda ; Pasoto, Sandra Gofinet; Shinjo, Samuel Katsuyuki ; Pereira, Rosa Maria Rodrigues ; Sartori, Ana Marli Christovam ; Duarte, Alberto José da Silva; Antonangelo, Leila ; Sabino, Ester Cerdeira ; Menezes, Paulo Rossi ; Kallas, Esper Georges ; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira
Fonte: Lancet rheumatology. Unidade: FM
Assuntos: IMUNOGENÉTICA, COVID-19, SISTEMA IMUNE, IMUNOGENICIDADE DA VACINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AIKAWA, Nadia E et al. Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study. Lancet rheumatology, v. 4, n. 2, p. E113-E124, 2022Tradução . . Disponível em: https://doi.org/10.1016/S2665-9913(21)00327-1. Acesso em: 02 dez. 2025.
APA
Aikawa, N. E., Kupa, L. de V. K., Pasoto, S. G., Shinjo, S. K., Pereira, R. M. R., Sartori, A. M. C., et al. (2022). Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study. Lancet rheumatology, 4( 2), E113-E124. doi:10.1016/S2665-9913(21)00327-1
NLM
Aikawa NE, Kupa L de VK, Pasoto SG, Shinjo SK, Pereira RMR, Sartori AMC, Duarte AJ da S, Antonangelo L, Sabino EC, Menezes PR, Kallas EG, Silva CAA da, Bonfa ESD de O. Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study [Internet]. Lancet rheumatology. 2022 ; 4( 2): E113-E124.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1016/S2665-9913(21)00327-1
Vancouver
Aikawa NE, Kupa L de VK, Pasoto SG, Shinjo SK, Pereira RMR, Sartori AMC, Duarte AJ da S, Antonangelo L, Sabino EC, Menezes PR, Kallas EG, Silva CAA da, Bonfa ESD de O. Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study [Internet]. Lancet rheumatology. 2022 ; 4( 2): E113-E124.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1016/S2665-9913(21)00327-1
Artigo de periodico
Adverse events following immunization of elderly with COVID-19 inactivated virus vaccine (CoronaVac) in Southeastern Brazil: an active surveillance study (2022)
Miyaji, Karina Takesaki; Itto, Lucas Yuji Umesaki; Jacintho, Lucas Cauê ; Sales, Amanda Caroline Ribeiro; Hiratsuka, Marcel; Leonel, Fabio Campos; Higa-taniguchi, Keila Tomoko; Picone, Camila Melo; Lara, Amanda Nazareth ; Rodrigues, Camila Cristina Martini; Lopes, Marta Heloísa ; Sartori, Ana Marli Christovam
Fonte: Revista do instituto de medicina tropical de sao paulo. Unidade: FM
Assuntos: COVID-19, IDOSOS, VULNERABILIDADE, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIYAJI, Karina Takesaki et al. Adverse events following immunization of elderly with COVID-19 inactivated virus vaccine (CoronaVac) in Southeastern Brazil: an active surveillance study. Revista do instituto de medicina tropical de sao paulo, v. 64, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50544. Acesso em: 02 dez. 2025.
APA
Miyaji, K. T., Itto, L. Y. U., Jacintho, L. C., Sales, A. C. R., Hiratsuka, M., Leonel, F. C., et al. (2022). Adverse events following immunization of elderly with COVID-19 inactivated virus vaccine (CoronaVac) in Southeastern Brazil: an active surveillance study. Revista do instituto de medicina tropical de sao paulo, 64. doi:10.1590/S1678-9946202264056
NLM
Miyaji KT, Itto LYU, Jacintho LC, Sales ACR, Hiratsuka M, Leonel FC, Higa-taniguchi KT, Picone CM, Lara AN, Rodrigues CCM, Lopes MH, Sartori AMC. Adverse events following immunization of elderly with COVID-19 inactivated virus vaccine (CoronaVac) in Southeastern Brazil: an active surveillance study [Internet]. Revista do instituto de medicina tropical de sao paulo. 2022 ; 64[citado 2025 dez. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50544
Vancouver
Miyaji KT, Itto LYU, Jacintho LC, Sales ACR, Hiratsuka M, Leonel FC, Higa-taniguchi KT, Picone CM, Lara AN, Rodrigues CCM, Lopes MH, Sartori AMC. Adverse events following immunization of elderly with COVID-19 inactivated virus vaccine (CoronaVac) in Southeastern Brazil: an active surveillance study [Internet]. Revista do instituto de medicina tropical de sao paulo. 2022 ; 64[citado 2025 dez. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50544
Artigo de periodico
An open-label randomized controlled parallel-group pilot study comparing the immunogenicity of a standard-, double-, and booster-dose regimens of the 2014 seasonal trivalent inactivated influenza vaccine in kidney transplant recipients (2022)
Odongo, Fatuma Catherine Atieno ; Braga, Patricia Emilia; Palacios, Ricardo; Miraglia, João Luiz ; Sartori, Ana Marli Christovam ; Ibrahim, Karim Yaqub; Lopes, Marta Heloisa ; Caiaffa-Filho, Helio Hehl; Timenetsky, Maria do Carmo Sampaio Tavares; Agena, Fabiana
Fonte: Transplantation. Unidade: FM
Assuntos: TRANSPLANTE DE FÍGADO, ESTUDOS RANDOMIZADOS, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ODONGO, Fatuma Catherine Atieno et al. An open-label randomized controlled parallel-group pilot study comparing the immunogenicity of a standard-, double-, and booster-dose regimens of the 2014 seasonal trivalent inactivated influenza vaccine in kidney transplant recipients. Transplantation, v. 106, n. 1, p. 210-220, 2022Tradução . . Disponível em: https://doi.org/10.1097/TP.0000000000003702. Acesso em: 02 dez. 2025.
APA
Odongo, F. C. A., Braga, P. E., Palacios, R., Miraglia, J. L., Sartori, A. M. C., Ibrahim, K. Y., et al. (2022). An open-label randomized controlled parallel-group pilot study comparing the immunogenicity of a standard-, double-, and booster-dose regimens of the 2014 seasonal trivalent inactivated influenza vaccine in kidney transplant recipients. Transplantation, 106( 1), 210-220. doi:10.1097/TP.0000000000003702
NLM
Odongo FCA, Braga PE, Palacios R, Miraglia JL, Sartori AMC, Ibrahim KY, Lopes MH, Caiaffa-Filho HH, Timenetsky M do CST, Agena F. An open-label randomized controlled parallel-group pilot study comparing the immunogenicity of a standard-, double-, and booster-dose regimens of the 2014 seasonal trivalent inactivated influenza vaccine in kidney transplant recipients [Internet]. Transplantation. 2022 ; 106( 1): 210-220.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1097/TP.0000000000003702
Vancouver
Odongo FCA, Braga PE, Palacios R, Miraglia JL, Sartori AMC, Ibrahim KY, Lopes MH, Caiaffa-Filho HH, Timenetsky M do CST, Agena F. An open-label randomized controlled parallel-group pilot study comparing the immunogenicity of a standard-, double-, and booster-dose regimens of the 2014 seasonal trivalent inactivated influenza vaccine in kidney transplant recipients [Internet]. Transplantation. 2022 ; 106( 1): 210-220.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1097/TP.0000000000003702
Artigo de periodico
Clinical profile and mortality in patients with T. cruzi/HIV co-infection from the multicenter data base of the “Network for healthcare and study of Trypanosoma cruzi/HIV co-infection and other immunosuppression conditions” (2021)
Shikanai-Yasuda, Maria Aparecida ; Mediano, Mauro Felippe Felix; Novaes, Christina Terra Gallafrio; Sousa, Andréa Silvestre de; Sartori, Ana Marli Christovam ; Santana, Rodrigo de Carvalho ; Correia, Dalmo; Castro, Cleudson Nery de; Severo, Marilia Maria dos Santos; Hasslocher-Moreno, Alejandro Marcel; Fernandez, Marisa Liliana; Salvador, Fernando; Pinazo, Maria Jesús; Bollela, Valdes Roberto
Fonte: PLOS Neglected Tropical Diseases. Unidades: FM, FMRP
Assuntos: SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA, DOENÇA DE CHAGAS, CONTAGEM DE LINFÓCITOS CD4, ASSISTÊNCIA À SAÚDE, IMUNOSSUPRESSÃO, TRYPANOSOMA CRUZI
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SHIKANAI-YASUDA, Maria Aparecida et al. Clinical profile and mortality in patients with T. cruzi/HIV co-infection from the multicenter data base of the “Network for healthcare and study of Trypanosoma cruzi/HIV co-infection and other immunosuppression conditions”. PLOS Neglected Tropical Diseases, v. 17, p. 1-18, 2021Tradução . . Disponível em: https://doi.org/10.1371/journal.pntd.0009809. Acesso em: 02 dez. 2025.
APA
Shikanai-Yasuda, M. A., Mediano, M. F. F., Novaes, C. T. G., Sousa, A. S. de, Sartori, A. M. C., Santana, R. de C., et al. (2021). Clinical profile and mortality in patients with T. cruzi/HIV co-infection from the multicenter data base of the “Network for healthcare and study of Trypanosoma cruzi/HIV co-infection and other immunosuppression conditions”. PLOS Neglected Tropical Diseases, 17, 1-18. doi:10.1371/journal.pntd.0009809
NLM
Shikanai-Yasuda MA, Mediano MFF, Novaes CTG, Sousa AS de, Sartori AMC, Santana R de C, Correia D, Castro CN de, Severo MM dos S, Hasslocher-Moreno AM, Fernandez ML, Salvador F, Pinazo MJ, Bollela VR. Clinical profile and mortality in patients with T. cruzi/HIV co-infection from the multicenter data base of the “Network for healthcare and study of Trypanosoma cruzi/HIV co-infection and other immunosuppression conditions” [Internet]. PLOS Neglected Tropical Diseases. 2021 ; 17 1-18.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1371/journal.pntd.0009809
Vancouver
Shikanai-Yasuda MA, Mediano MFF, Novaes CTG, Sousa AS de, Sartori AMC, Santana R de C, Correia D, Castro CN de, Severo MM dos S, Hasslocher-Moreno AM, Fernandez ML, Salvador F, Pinazo MJ, Bollela VR. Clinical profile and mortality in patients with T. cruzi/HIV co-infection from the multicenter data base of the “Network for healthcare and study of Trypanosoma cruzi/HIV co-infection and other immunosuppression conditions” [Internet]. PLOS Neglected Tropical Diseases. 2021 ; 17 1-18.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1371/journal.pntd.0009809
Artigo de periodico
Cost-effectiveness analysis of universal adult immunization with tetanus-diphtheria-acellular pertussis vaccine (Tdap) versus current practice in Brazil (2020)
Fernandes, Eder Gatti; Sartori, Ana Marli Christovam ; Soarez, Patricia Coelho de ; Amaku, Marcos ; Azevedo Neto, Raymundo Soares de ; Novaes, Hillegonda Maria Dutilh
Fonte: Vaccine. Unidade: FM
Assuntos: CUSTOS DOS CUIDADOS DE SAÚDE, IMUNIZAÇÃO, CAMPANHAS DE VACINAÇÃO, TÉTANO, DIFTERIA, COQUELUCHE, ADULTOS, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Eder Gatti et al. Cost-effectiveness analysis of universal adult immunization with tetanus-diphtheria-acellular pertussis vaccine (Tdap) versus current practice in Brazil. Vaccine, v. 38, n. 1, p. 46-53, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2019.09.100. Acesso em: 02 dez. 2025.
APA
Fernandes, E. G., Sartori, A. M. C., Soarez, P. C. de, Amaku, M., Azevedo Neto, R. S. de, & Novaes, H. M. D. (2020). Cost-effectiveness analysis of universal adult immunization with tetanus-diphtheria-acellular pertussis vaccine (Tdap) versus current practice in Brazil. Vaccine, 38( 1), 46-53. doi:10.1016/j.vaccine.2019.09.100
NLM
Fernandes EG, Sartori AMC, Soarez PC de, Amaku M, Azevedo Neto RS de, Novaes HMD. Cost-effectiveness analysis of universal adult immunization with tetanus-diphtheria-acellular pertussis vaccine (Tdap) versus current practice in Brazil [Internet]. Vaccine. 2020 ; 38( 1): 46-53.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2019.09.100
Vancouver
Fernandes EG, Sartori AMC, Soarez PC de, Amaku M, Azevedo Neto RS de, Novaes HMD. Cost-effectiveness analysis of universal adult immunization with tetanus-diphtheria-acellular pertussis vaccine (Tdap) versus current practice in Brazil [Internet]. Vaccine. 2020 ; 38( 1): 46-53.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2019.09.100
Artigo de periodico
Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report (2019)
Wilder-smith, A; Smith, P. G; Luo, R; Kelly-cirino, C; Curry, D; Larson, H; Durbin, A; Chu, M; Sartori, Ana Marli Christovam ; Luna, Expedito José de Albuquerque
Fonte: Vaccine. Unidade: FM
Assuntos: DENGUE, VACINAS VIRAIS, PROGRAMAS DE VACINAÇÃO, TRIAGEM DE MASSA, CAMPANHAS DE VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILDER-SMITH, A et al. Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report. Vaccine, v. 37, n. 36, p. 5137-5146, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2019.07.016. Acesso em: 02 dez. 2025.
APA
Wilder-smith, A., Smith, P. G., Luo, R., Kelly-cirino, C., Curry, D., Larson, H., et al. (2019). Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report. Vaccine, 37( 36), 5137-5146. doi:10.1016/j.vaccine.2019.07.016
NLM
Wilder-smith A, Smith PG, Luo R, Kelly-cirino C, Curry D, Larson H, Durbin A, Chu M, Sartori AMC, Luna EJ de A. Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report [Internet]. Vaccine. 2019 ; 37( 36): 5137-5146.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2019.07.016
Vancouver
Wilder-smith A, Smith PG, Luo R, Kelly-cirino C, Curry D, Larson H, Durbin A, Chu M, Sartori AMC, Luna EJ de A. Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report [Internet]. Vaccine. 2019 ; 37( 36): 5137-5146.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2019.07.016
Artigo de periodico
Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016) (2019)
Mauro, Alexandre Blikstad; Fernandes, Eder Gatti; Miyaji, Karina Takesaki; Arantes, Benedito Antonio; Valente, Maria Gomes; Sato, Helena Keico; Sartori, Ana Marli Christovam
Fonte: Revista do instituto de medicina tropical de sao paulo. Unidade: FM
Assuntos: VACINAS VIRAIS, INFECÇÕES POR PAPILLOMAVIRUS, HPV, VIGILÂNCIA EPIDEMIOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAURO, Alexandre Blikstad et al. Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016). Revista do instituto de medicina tropical de sao paulo, v. 61, 2019Tradução . . Disponível em: https://doi.org/10.1590/S1678-9946201961043. Acesso em: 02 dez. 2025.
APA
Mauro, A. B., Fernandes, E. G., Miyaji, K. T., Arantes, B. A., Valente, M. G., Sato, H. K., & Sartori, A. M. C. (2019). Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016). Revista do instituto de medicina tropical de sao paulo, 61. doi:10.1590/S1678-9946201961043
NLM
Mauro AB, Fernandes EG, Miyaji KT, Arantes BA, Valente MG, Sato HK, Sartori AMC. Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016) [Internet]. Revista do instituto de medicina tropical de sao paulo. 2019 ; 61[citado 2025 dez. 02 ] Available from: https://doi.org/10.1590/S1678-9946201961043
Vancouver
Mauro AB, Fernandes EG, Miyaji KT, Arantes BA, Valente MG, Sato HK, Sartori AMC. Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016) [Internet]. Revista do instituto de medicina tropical de sao paulo. 2019 ; 61[citado 2025 dez. 02 ] Available from: https://doi.org/10.1590/S1678-9946201961043
Artigo de periodico
A systematic review of adult tetanus-diphtheria-acellular (Tdap) coverage among healthcare workers (2019)
Randi, Bruno A; Sejas, Odeli Nicole Encinas; Miyaji, Karina T; Infante, Vanessa; Lara, Amanda N; Ibrahim, Karim Y; Lopes, Marta Heloísa; Sartori, Ana Marli Christovam
Fonte: Vaccine. Unidade: FM
Assuntos: TÉTANO, DIFTERIA, IMUNIZAÇÃO, VACINAÇÃO, REVISÃO SISTEMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RANDI, Bruno A et al. A systematic review of adult tetanus-diphtheria-acellular (Tdap) coverage among healthcare workers. Vaccine, v. 37, n. 8, p. 1030-1037, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2018.12.046. Acesso em: 02 dez. 2025.
APA
Randi, B. A., Sejas, O. N. E., Miyaji, K. T., Infante, V., Lara, A. N., Ibrahim, K. Y., et al. (2019). A systematic review of adult tetanus-diphtheria-acellular (Tdap) coverage among healthcare workers. Vaccine, 37( 8), 1030-1037. doi:10.1016/j.vaccine.2018.12.046
NLM
Randi BA, Sejas ONE, Miyaji KT, Infante V, Lara AN, Ibrahim KY, Lopes MH, Sartori AMC. A systematic review of adult tetanus-diphtheria-acellular (Tdap) coverage among healthcare workers [Internet]. Vaccine. 2019 ; 37( 8): 1030-1037.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2018.12.046
Vancouver
Randi BA, Sejas ONE, Miyaji KT, Infante V, Lara AN, Ibrahim KY, Lopes MH, Sartori AMC. A systematic review of adult tetanus-diphtheria-acellular (Tdap) coverage among healthcare workers [Internet]. Vaccine. 2019 ; 37( 8): 1030-1037.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2018.12.046
Artigo de periodico
Low tetanus-diphtheria-acellular pertussis (Tdap) vaccine coverage among healthcare workers in a quaternary university hospital in Sao Paulo, Brazil: need for continuous surveillance and implementation of active strategies (2019)
Randi, Bruno Azevedo; Miyaji, Karina Takesaki; Lara, Amanda Nazareth; Ibrahim, Karim Yaqub; Infante, Vanessa; Rodrigues, Camila Cristina Martines; Lopes, Marta Heloísa ; Sartori, Ana Marli Christovam
Fonte: Brazilian journal of infectious diseases. Unidade: FM
Assuntos: TÉTANO, DIFTERIA, COQUELUCHE, VACINAÇÃO, HOSPITAIS UNIVERSITÁRIOS, SERVIÇOS PREVENTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RANDI, Bruno Azevedo et al. Low tetanus-diphtheria-acellular pertussis (Tdap) vaccine coverage among healthcare workers in a quaternary university hospital in Sao Paulo, Brazil: need for continuous surveillance and implementation of active strategies. Brazilian journal of infectious diseases, v. 23, n. 4, p. 231-236, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.bjid.2019.06.007. Acesso em: 02 dez. 2025.
APA
Randi, B. A., Miyaji, K. T., Lara, A. N., Ibrahim, K. Y., Infante, V., Rodrigues, C. C. M., et al. (2019). Low tetanus-diphtheria-acellular pertussis (Tdap) vaccine coverage among healthcare workers in a quaternary university hospital in Sao Paulo, Brazil: need for continuous surveillance and implementation of active strategies. Brazilian journal of infectious diseases, 23( 4), 231-236. doi:10.1016/j.bjid.2019.06.007
NLM
Randi BA, Miyaji KT, Lara AN, Ibrahim KY, Infante V, Rodrigues CCM, Lopes MH, Sartori AMC. Low tetanus-diphtheria-acellular pertussis (Tdap) vaccine coverage among healthcare workers in a quaternary university hospital in Sao Paulo, Brazil: need for continuous surveillance and implementation of active strategies [Internet]. Brazilian journal of infectious diseases. 2019 ; 23( 4): 231-236.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1016/j.bjid.2019.06.007
Vancouver
Randi BA, Miyaji KT, Lara AN, Ibrahim KY, Infante V, Rodrigues CCM, Lopes MH, Sartori AMC. Low tetanus-diphtheria-acellular pertussis (Tdap) vaccine coverage among healthcare workers in a quaternary university hospital in Sao Paulo, Brazil: need for continuous surveillance and implementation of active strategies [Internet]. Brazilian journal of infectious diseases. 2019 ; 23( 4): 231-236.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1016/j.bjid.2019.06.007

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada